FierceBiotech ١٤ أبريل ٢٠٢٦ Boehringer, Amgen discard early immunology candidates over lack of clinical potential
FierceBiotech ٣٠ مارس ٢٠٢٦ Viridian’s other rival to Amgen’s Tepezza scores phase 3 win, but investors need convincing
FierceBiotech ٤ فبراير ٢٠٢٦ Amgen advances toward lupus redemption while gastric cancer candidate struggles
FierceBiotech ٣٠ يناير ٢٠٢٦ Amgen jilts Kyowa, exiting $400M autoimmune pact after running vast pivotal program
FierceBiotech ١٣ يناير ٢٠٢٦ JPM26, Day 2: Amgen touts MariTide's showing in exploratory weight loss maintenance study
FierceBiotech ٦ يناير ٢٠٢٦ Amgen stitches new acquisition worth up to $840M for UK biotech and its cancer programs
FierceBiotech ١١ ديسمبر ٢٠٢٥ Amgen obesity marketing leader Chris Boulton takes reins at metabolic biotech Prolynx